C132H118F4N30O3 — CID 158770893
6-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]quinazoline;6-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]-3H-quinazolin-4-one;4-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]quinoline-6-carboxamide;7-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]quinoxaline-2-carboxamide;6-[2-[2-(3-methylphenyl)ethyl]-5-(1-methylpyrazol-3-yl)-1H-imidazol-4-yl]quinoline (PubChem CID 158770893) has the molecular formula C132H118F4N30O3 and a molecular weight of 2248.59 g/mol. Its IUPAC name is 6-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]quinazoline;6-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]-3H-quinazolin-4-one;4-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]quinoline-6-carboxamide;7-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]quinoxaline-2-carboxamide;6-[2-[2-(3-methylphenyl)ethyl]-5-(1-methylpyrazol-3-yl)-1H-imidazol-4-yl]quinoline.
| Compound Name | 6-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]quinazoline;6-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]-3H-quinazolin-4-one;4-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]quinoline-6-carboxamide;7-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]quinoxaline-2-carboxamide;6-[2-[2-(3-methylphenyl)ethyl]-5-(1-methylpyrazol-3-yl)-1H-imidazol-4-yl]quinoline |
|---|---|
| PubChem CID | 158770893 |
| Molecular Formula | C132H118F4N30O3 |
| Molecular Weight | 2248.59 g/mol |
| Exact Mass | 2246.99 |
| IUPAC Name | 6-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]quinazoline;6-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]-3H-quinazolin-4-one;4-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]quinoline-6-carboxamide;7-[5-(1-cyclopropylpyrazol-3-yl)-2-[2-(3-fluoro-5-methylphenyl)ethyl]-1H-imidazol-4-yl]quinoxaline-2-carboxamide;6-[2-[2-(3-methylphenyl)ethyl]-5-(1-methylpyrazol-3-yl)-1H-imidazol-4-yl]quinoline |
| SMILES | Cc1cc(F)cc(CCc2nc(-c3ccc4nc[nH]c(=O)c4c3)c(-c3ccn(C4CC4)n3)[nH]2)c1.Cc1cc(F)cc(CCc2nc(-c3ccc4ncc(C(N)=O)nc4c3)c(-c3ccn(C4CC4)n3)[nH]2)c1.Cc1cc(F)cc(CCc2nc(-c3ccc4ncncc4c3)c(-c3ccn(C4CC4)n3)[nH]2)c1.Cc1cc(F)cc(CCc2nc(-c3ccnc4ccc(C(N)=O)cc34)c(-c3ccn(C4CC4)n3)[nH]2)c1.Cc1cccc(CCc2nc(-c3ccc4ncccc4c3)c(-c3ccn(C)n3)[nH]2)c1 |
| InChI | InChI=1S/C28H25FN6O.C27H24FN7O.C26H23FN6O.C26H23FN6.C25H23N5/c1-16-12-17(14-19(29)13-16)2-7-25-32-26(27(33-25)24-9-11-35(34-24)20-4-5-20)21-8-10-31-23-6-3-18(28(30)36)15-22(21)23;1-15-10-16(12-18(28)11-15)2-7-24-32-25(26(33-24)21-8-9-35(34-21)19-4-5-19)17-3-6-20-22(13-17)31-23(14-30-20)27(29)36;1-15-10-16(12-18(27)11-15)2-7-23-30-24(17-3-6-21-20(13-17)26(34)29-14-28-21)25(31-23)22-8-9-33(32-22)19-4-5-19;1-16-10-17(12-20(27)11-16)2-7-24-30-25(18-3-6-22-19(13-18)14-28-15-29-22)26(31-24)23-8-9-33(32-23)21-4-5-21;1-17-5-3-6-18(15-17)8-11-23-27-24(25(28-23)22-12-14-30(2)29-22)20-9-10-21-19(16-20)7-4-13-26-21/h3,6,8-15,20H,2,4-5,7H2,1H3,(H2,30,36)(H,32,33);3,6,8-14,19H,2,4-5,7H2,1H3,(H2,29,36)(H,32,33);3,6,8-14,19H,2,4-5,7H2,1H3,(H,30,31)(H,28,29,34);3,6,8-15,21H,2,4-5,7H2,1H3,(H,30,31);3-7,9-10,12-16H,8,11H2,1-2H3,(H,27,28) |
| InChIKey | IPVUGCWIWMHATP-UHFFFAOYSA-N |
| XLogP | 25.02 |
| TPSA | 441.77 Ų |
| H-Bond Donors | 8 |
| H-Bond Acceptors | 25 |
| Rotatable Bonds | 31 |
| Heavy Atoms | 169 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2248.59 |
| LogP ≤ 5 | 25.02 |
| H-Bond Donors ≤ 5 | 8 |
| H-Bond Acceptors ≤ 10 | 25 |